Clinical Trials at Children's Hospital of The King's Daughters
As of August 2026, 38 paid clinical trials are recruiting at Children's Hospital of The King's Daughters, located at 601 CHILDRENS LN, NORFOLK, VA 23507-1910, phone (757) 668-7017 in Norfolk, Virginia. Active studies at this site cover conditions such as Breast Cancer, Heart Failure and Duchenne Muscular Dystrophy. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
38 clinical trials at Children's Hospital of The King's Daughters
·Clear filters·Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Child and Adolescent Registry for Participants With Narcolepsy
Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age
A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)
A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort
Sleep Treatment for Teens (RCT Phase)
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Project: Every Child for Younger Patients With Cancer
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Beat Childhood Cancer Specimen Banking and Data Registry
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Common conditions studied in Norfolk
- Breast Cancer (9 active studies)
- Heart Failure (9 active studies)
- Duchenne Muscular Dystrophy (6 active studies)
- Breast Neoplasms (5 active studies)
- Multiple Myeloma (5 active studies)
- Acute Myeloid Leukemia (4 active studies)
Leading research sponsors in Norfolk
- AstraZeneca
- Children's Oncology Group
- National Cancer Institute (NCI)
- Pfizer
- Eli Lilly and Company
Frequently asked questions
How many paid clinical trials are currently recruiting in Norfolk?
There are approximately 294 recruiting clinical trials in Norfolk, Virginia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Norfolk pay participants?
Most recruiting trials in Norfolk compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Norfolk?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Norfolk?
The most common conditions under active study in Norfolk include Breast Cancer (9), Heart Failure (9), Duchenne Muscular Dystrophy (6), Breast Neoplasms (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Norfolk?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Norfolk on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Norfolk?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Norfolk?
Recruiting research sites in Norfolk include Virginia Oncology Associates, Children's Hospital of The King's Daughters, Sentara Norfolk General Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Norfolk right now?
The largest active categories in Norfolk are Cancer & tumors (85), Cardiovascular (26), Neurology & pain (16). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Children's Hospital of The King's Daughters?
Children's Hospital of The King's Daughters is located at 601 CHILDRENS LN, NORFOLK, VA 23507-1910. Use the Google Maps link in the intro above to get directions.
How do I contact Children's Hospital of The King's Daughters?
You can reach Children's Hospital of The King's Daughters by phone at (757) 668-7017. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.